{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:24:24Z","timestamp":1792121064830,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1023\/a:1017903724176","type":"journal-article","created":{"date-parts":[[2002,12,30]],"date-time":"2002-12-30T14:36:44Z","timestamp":1041259004000},"page":"9-19","source":"Crossref","is-referenced-by-count":24,"title":["Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer"],"prefix":"10.1007","volume":"68","author":[{"given":"Roberta","family":"D'Alessandro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Roselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Ferroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Spila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Aloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Daniela","family":"Carone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Abbolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ricciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Botti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Vici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neva Rossi","family":"Chiappetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cognetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oreste","family":"Buonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Guadagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"352252_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/172460088900400405","volume":"44","author":"F Safi","year":"1989","unstructured":"Safi F, Kohler I, Rottinger E, Suhr P, Beger HG: Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer. Int J Biol Markers 44: 207-214, 1989","journal-title":"Int J Biol Markers"},{"key":"352252_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0009-8981(91)90080-V","volume":"200","author":"AM Dnistrian","year":"1991","unstructured":"Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA Schwartz DC: CA 15-3 and carcinoembryonic antigen in the clinical evaluation of breast cancer. Clin Chim Acta 200: 81-93, 1991","journal-title":"Clin Chim Acta"},{"key":"352252_CR3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000217692","volume":"12","author":"AM Dnistrian","year":"1991","unstructured":"Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Schwartz DC: Evaluation of CA M26, CA M29, CA 15-3 and CEA as circulating tumor markers in breast cancer patients. Tumour Biol 12: 82-90, 1991","journal-title":"Tumour Biol"},{"key":"352252_CR4","first-page":"74","volume":"19","author":"MA al-Jarallah","year":"1993","unstructured":"al-Jarallah MA, Behbehani AE, el-Nass SA, Temim L, Ebraheem AK, Ali MA, Szymendera JJ: Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma. Eur J Surg Oncol 19: 74-79, 1993","journal-title":"Eur J Surg Oncol"},{"key":"352252_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00690183","volume":"36","author":"R Molina","year":"1995","unstructured":"Molina R, Zan\u00d3n G, Filella X, Moreno F, Jo J, Daniels M, Latre ML, Gimenez N, Pahisa J, Velasco M, Ballesta AM: Use of serial carcinoembryonic antigen and CA 15-3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36: 41-48, 1995","journal-title":"Breast Cancer Res Treat"},{"key":"352252_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/00365519509090570","volume":"221","author":"W Jager","year":"1995","unstructured":"Jager W, Kramer S, Palapelas V, Norbert L: Breast cancer and clinical utility of CA 15-3 and CEA. Scand J Clin Lab Invest Suppl 221: 87-92, 1995","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"352252_CR7","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000217926","volume":"16","author":"AM Ballesta","year":"1995","unstructured":"Ballesta AM, Molina R, Filella X, Jo J, Gimenez N: Carcinoembryonic antigen in staging and follow-up of patients with solid tumors. Tumour Biol 16: 32-41, 1995","journal-title":"Tumour Biol"},{"key":"352252_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3835(96)04473-4","volume":"110","author":"B Jezersek","year":"1996","unstructured":"Jezersek B, Cervek J, Rudolf Z, Novakovic S: Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients. Cancer Lett 110: 137-144, 1996","journal-title":"Cancer Lett"},{"key":"352252_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1023\/A:1005734429304","volume":"51","author":"R Molina","year":"1998","unstructured":"Molina R, Jo J, Filella X, Zanon G, Pahisa J, Munoz M, Farrus B, Latre ML, Escriche C, Estape J, Ballesta AM: c-erbB-2 oncoprotein, CEA, and CA 15-3 in patients with breast cancer: prognostic value. Breast Cancer Res Treat 51: 109-119, 1998","journal-title":"Breast Cancer Res Treat"},{"key":"352252_CR10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.121.3.439","volume":"121","author":"P. Gold","year":"1965","unstructured":"Gold P., Freedman S.O.: Demonstration of tumor-specific antigens in human colonic carcinomata by immunologic tolerance and absorption techniques. J Exp Med 121: 439-466, 1965","journal-title":"J Exp Med"},{"key":"352252_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1200\/JCO.1986.4.1.46","volume":"4","author":"CL Loprinzi","year":"1986","unstructured":"Loprinzi CL, Tormey DC, Rassmussen P, Falkson G, Davis TE, Falkson HC, Chang AY: Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in breast cancer. J Clin Oncol 4: 46-56, 1986","journal-title":"J Clin Oncol"},{"key":"352252_CR12","first-page":"4107","volume":"48","author":"C Tondini","year":"1988","unstructured":"Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW: Comparison of CA15.3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res 48: 4107-4112, 1988","journal-title":"Cancer Res"},{"key":"352252_CR13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bjc.1987.115","volume":"55","author":"DMF Pons-Anicet","year":"1987","unstructured":"Pons-Anicet DMF, Krebs BP, Mira R, Namer M: Value of CA15.3 in the follow-up of breast cancer patients. Br J Cancer 55: 567-569, 1987","journal-title":"Br J Cancer"},{"key":"352252_CR14","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/1097-0142(19891015)64:8<1674::AID-CNCR2820640820>3.0.CO;2-V","volume":"64","author":"R Colomer","year":"1989","unstructured":"Colomer R, Ruibal A, Salvador L: Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Cancer 64: 1674-1681, 1989","journal-title":"Cancer"},{"key":"352252_CR15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/1097-0142(19910801)68:3<574::AID-CNCR2820680322>3.0.CO;2-B","volume":"68","author":"F Safi","year":"1991","unstructured":"Safi F, Kohler I, Rottinger E, Beger HG: The value of the tumormarker CA15.3 in diagnosis and monitoring breast cancer. Cancer 68: 574-582, 1991","journal-title":"Cancer"},{"key":"352252_CR16","unstructured":"Guadagni F, Ferroni P, Carlini S, Mariotti S, Spila A, Aloe S, D'Alessandro R, Carone MD, Cicchetti A, Ricciotti A, Venturo I, Perri P, Di Filippo F, Cognetti F, Botti C, Roselli M: A reevaluation of CEA as serum marker for breast cancer-A prospective longitudinal study. Clin Cancer Res, 2001 (In Press)"},{"key":"352252_CR17","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1172\/JCI111875","volume":"75","author":"DF Hayes","year":"1985","unstructured":"Hayes DF, Sekine H, Ohno T, Abe M, Keefe K, Kufe DW: Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients. J Clin Invest 75: 1671-1678, 1985","journal-title":"J Clin Invest"},{"key":"352252_CR18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0889-8588(18)30525-2","volume":"3","author":"C Tondini","year":"1989","unstructured":"Tondini C, Hayes DF, Kufe DW: Circulating tumor markers in breast cancer. Hematol Oncol Clin North Am 3: 653-674, 1989","journal-title":"Hematol Oncol Clin North Am"},{"key":"352252_CR19","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1200\/JCO.1986.4.10.1542","volume":"4","author":"DF Hayes","year":"1986","unstructured":"Hayes DF, Zurawski VR, Kufe DW: Comparison of circulating CA 15-3 and CEA levels in patients with breast cancer. J Clin Oncol 4: 1542-1550, 1986","journal-title":"J Clin Oncol"},{"key":"352252_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00689716","volume":"34","author":"PL Devine","year":"1995","unstructured":"Devine PL, Duroux MA, Quin RJ, McGuckin MA, Joy GJ, Ward BG, Pollard CW: CA 15-3, CASA, MSA, and TPS as diagnostic serum markers in breast cancer. Breast Cancer Res Treat 34: 245-251, 1995","journal-title":"Breast Cancer Res Treat"},{"key":"352252_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/172460089100600301","volume":"6","author":"AM Dnistrian","year":"1991","unstructured":"Dnistrian AM, Schwartz MK, Greenberg EJ, Smith CA, Dorsa R, Schwartz DC: CA 549 as a marker in breast cancer. Int J Biol Markers 6: 139-143, 1991","journal-title":"Int J Biol Markers"},{"key":"352252_CR22","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000217894","volume":"15","author":"JM Bonfrer","year":"1994","unstructured":"Bonfrer JM, Groeneveld EM, Korse CM, van Dalen A, Oomen LC, Ivanyi D: Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumor Biol 15: 210-222, 1994","journal-title":"Tumor Biol"},{"key":"352252_CR23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-1033.1996.00309.x","volume":"241","author":"L Rydlander","year":"1996","unstructured":"Rydlander L, Ziegler E, Bergman T, Sch\u00f6berl E, Steiner G, Bergman AC, Zetterberg A, Marberger M, Bj\u00f6rklund P, Skern T, Einersson R, J\u00f6rnvall H: Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 241: 309-314, 1996.","journal-title":"Eur J Biochem"},{"key":"352252_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000228374","volume":"10","author":"B Bj\u00f6rklund","year":"1957","unstructured":"Bj\u00f6rklund B, Bj\u00f6rklund V: Antigenicity of a pooled human malignant and normal tissues by cyto-immunological technique. Presence of an insoluble, heat-labile tumor antigen. Int Arch Allergy 10: 153-184, 1957","journal-title":"Int Arch Allergy"},{"key":"352252_CR25","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/0959-8049(94)00232-T","volume":"30","author":"JL Pujol","year":"1994","unstructured":"Pujol JL, Cooper EH, Grenier J, Purves DA, Lehmann M, Ray P, Aouta MD, Bashir M, Godard P, Michel FB: Clinical evaluation of serum tissue polypeptide specific antigen in non-small cell lung cancer. Eur J Cancer 30: 1768-1774, 1994","journal-title":"Eur J Cancer"},{"key":"352252_CR26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1046\/j.1525-1500.1998.00053.x","volume":"22","author":"B Nisman","year":"1998","unstructured":"Nisman B, Barak V, Heching N, Kramer M, Reinus C, Lafair J: Cytokeratin markers in malignant pleural mesothelioma. Cancer Detect Prev 22: 416-421, 1998","journal-title":"Cancer Detect Prev"},{"key":"352252_CR27","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1018::AID-CNCR2>3.0.CO;2-R","volume":"85","author":"RM Nagler","year":"1999","unstructured":"Nagler RM, Barak M, Peled M, Ben-Aryeh H, Filatov M, Laufer D: Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85: 1018-1025, 1999","journal-title":"Cancer"},{"key":"352252_CR28","first-page":"298","volume":"20","author":"A Zygmunt","year":"1999","unstructured":"Zygmunt A, Madry R, Markowska J, Fischer Z: Estimation of the usefulness of neoplastic markers TPS and CA 125 in diagnosis and monitoring of ovarian cancer. Eur J Gynaecol Oncol 20: 298-301, 1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"352252_CR29","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0045(19971101)33:3<208::AID-PROS10>3.0.CO;2-O","volume":"33","author":"M Polito","year":"1997","unstructured":"Polito M, Minardi D, Recchioni A, Giannulis I, De Sio G, Muzzonigro G: Serum markers for monitoring of prostatic carcinoma. Prostate 33: 208-216, 1997","journal-title":"Prostate"},{"key":"352252_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/(SICI)1097-0215(19980619)79:3<241::AID-IJC5>3.0.CO;2-P","volume":"79","author":"C Tempfer","year":"1998","unstructured":"Tempfer C, Hefler L, Haeusler G, Reinthaller A, Koelbl H, Zeisler H, Kainz C: Tissue polypeptide specific antigen in the follow-up of ovarian and cervical cancer patients. Int J Cancer 79: 241-244, 1998","journal-title":"Int J Cancer"},{"key":"352252_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000217747","volume":"13","author":"A Van Dalen","year":"1992","unstructured":"Van Dalen A: TPS in breast cancer-A comparative study with carcinoembryonic antigen and CA 15-3. Tumor Biol 13: 10-17, 1992","journal-title":"Tumor Biol"},{"key":"352252_CR32","first-page":"65","volume":"10","author":"AB Halim","year":"1995","unstructured":"Halim AB, El-Ahmady O, Al-Ghazzawy I: The clinical value of serum tissue polypeptide specific antigen (TPS) in breast cancer patients. J Tumor Marker Oncol 10: 65-70, 1995","journal-title":"J Tumor Marker Oncol"},{"key":"352252_CR33","first-page":"363","volume":"5","author":"D Karaloglu","year":"1995","unstructured":"Karaloglu D, Yasasever V, Ert\u00fcrk N, Dalay N: The value of TPS in breast cancer. Eur J Gynaec Oncol 5: 363-367, 1995","journal-title":"Eur J Gynaec Oncol"},{"key":"352252_CR34","first-page":"875","volume":"16","author":"M Giai","year":"1996","unstructured":"Giai M, Roagna R, Ponzone R, Biglia N, Sgro L Perona M, Sismondi P: TPS and CA 15-3 serum values as a guide for treating and monitoring breast cancer patients. Anticancer Res 16: 875-881, 1996","journal-title":"Anticancer Res"},{"key":"352252_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0748-7983(96)91385-2","volume":"22","author":"DM O'Hanlon","year":"1996","unstructured":"O'Hanlon DM, Kerin MJ, O'Boyle C, Grimes H, Given HF: Tissue polypeptide specific antigen (TPS) in breast cancer-an initial evaluation. Eur J Surg Oncol 22: 38-41, 1996","journal-title":"Eur J Surg Oncol"},{"key":"352252_CR36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/172460088900400405","volume":"4","author":"F Safi","year":"1989","unstructured":"Safi F, Kohler I, R\u00f6ttinger E, Suhr P, Beger HG: Comparison of CA 15-3 and CEA in diagnosis and monitoring of breast cancer. Int J Biol Markers 4: 207-214, 1989","journal-title":"Int J Biol Markers"},{"key":"352252_CR37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/172460089801300103","volume":"13","author":"A Van Dalen","year":"1998","unstructured":"Van Dalen A, Barak V, Cremaschi A, Gion M, Molina R Namer M, Stieber P, Sturgeon C, Einarsson R: The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease. Int J Biol Markers 13: 10-15, 1998","journal-title":"Int J Biol Markers"},{"key":"352252_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/172460089901400109","volume":"14","author":"A van Dalen","year":"1999","unstructured":"van Dalen A: TPS monitoring in metastatic breast cancer. Int J Biol Markers 14: 45-48, 1999","journal-title":"Int J Biol Markers"},{"key":"352252_CR39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/172460089601100403","volume":"11","author":"HG Vibert","year":"1996","unstructured":"Vibert HG, Houston AS, Wilkins GP, Kemp PM Macleod MA: CA549 and TPS patterns in the diagnosis and staging of patients with breast carcinoma. Int J Biol Markers 11: 198-202, 1996","journal-title":"Int J Biol Markers"},{"key":"352252_CR40","first-page":"2963","volume":"17","author":"M Sutterlin","year":"1997","unstructured":"Sutterlin M, Oehler MK, Caffier H: Clinical value of CYFRA 8\/18 and TPS in the diagnosis and follow up of invasive breast cancer. Anticancer Res 17: 2963-2965, 1997","journal-title":"Anticancer Res"},{"key":"352252_CR41","first-page":"1231","volume":"17","author":"M Eskelinen","year":"1997","unstructured":"Eskelinen M, Kataja V, Hamalainen E, Kosma VM, Penttila I, Alhava E: Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer. Anticancer Res 17: 1231-1234, 1997","journal-title":"Anticancer Res"},{"key":"352252_CR42","first-page":"218","volume":"11","author":"A Semjonof","year":"1993","unstructured":"Semjonof A, Hamm M and Rathert P: Prediction of tumor recurrence after radical prostatectomy using elimination kinetics of prostate-specific antigen. World Urol 11: 218-220, 1993","journal-title":"World Urol"},{"key":"352252_CR43","first-page":"2241","volume":"16","author":"A Spila","year":"1996","unstructured":"Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, Tedesco M, Carlini S, D'Alessandro R, Perri P, Casciani CU, Greiner JW, Schlom J and Guadagni F: Clinical utility of CA 72-4 serum marker in the staging and immediate postsurgical management of gastric cancer patients. Anticancer Res 16: 2241-2248, 1996","journal-title":"Anticancer Res"},{"key":"352252_CR44","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1365-2133.1995.tb06912.x","volume":"133","author":"M Kallioinen","year":"1995","unstructured":"Kallioinen M, Koivukangas V, J\u00e4rvinen M, Oikarinen A: Expression of cytokeratins in regenerating human epidermis. Br J Dermatol 133: 830-835, 1995","journal-title":"Br J Dermatol"},{"key":"352252_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/bjc.1991.260","volume":"64","author":"A Nicolini","year":"1991","unstructured":"Nicolini A, Colombini C, Luciani L, Carpi A, Giuliani L: Evaluation of serum CA 15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients. Br J Cancer 64: 154-158, 1991","journal-title":"Br J Cancer"},{"key":"352252_CR46","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000218043","volume":"18","author":"A Bottini","year":"1997","unstructured":"Bottini A, Berruti A, Tampellini M, Morrica B, Brunelli A, Gnocchi E, Brizzi MP, Aguggini S, Fara E, Alquati P Dogliotti L: Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease. Tumour Biol 18: 301-310, 1997","journal-title":"Tumour Biol"},{"key":"352252_CR47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0960-9776(96)90126-5","volume":"5","author":"A Van Dalen","year":"1996","unstructured":"Van Dalen A, Heering JK, Barak V, Peretz T, Cremaschi A, Geroni P, Gion M, Saracchini S, Molina R, Namer M, Stieber P, Sturgeon C, Leonard RCF, Einarsson R: Treatment response in metastatic breast cancer. A multicentre study comparing UICC criteria and tumor marker changes. The Breast 5: 82-88, 1996","journal-title":"The Breast"},{"key":"352252_CR48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF01269892","volume":"123","author":"LC Pronk","year":"1997","unstructured":"Pronk LC, Stoter G, van Putten WLJ, de Wit R: The correlation of CA 15-3 and TPS with tumor course in patients with metastatic breast cancer. J Cancer Res Clin Oncol 123: 128-132, 1997","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017903724176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1017903724176\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1017903724176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1017903724176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:30:50Z","timestamp":1750480250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1017903724176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["352252"],"URL":"https:\/\/doi.org\/10.1023\/a:1017903724176","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}